Prostate cancer
Manuscript 2 Practice 2026: TITAN post hoc analysis

A patient with high-burden mHSPC: should we intensify treatment?

Man, 72 years old, presents with increasing lower back pain and weight loss over 3 months.

Assessment summary:

  • Medical history:
    • 3 years ago: radical prostatectomy for T2N0M0 PCa, ISUP grade group 4 (Gleason score 4+5)
    • 2 years ago: early prostate bed salvage RT without ADT for biochemical recurrence (PSA: 0.36 ng/ml)

He was lost to follow-up as he had moved across the country, and presents again today:

  • Comorbidities: hypertension (well controlled), no diabetes, no cardiovascular events
  • BPI-SF pain score: 6/10, requiring regular NSAIDs
  • ECOG PS: 1
  • PSA: 210 ng/ml
  • CT and bone scan:
    • Multiple enlarged pelvic and paraaortic lymph nodes, no liver lesions, no other visceral disease
    • Numerous bone lesions throughout spine, pelvis, ribs, and proximal femora; report estimates >20 discrete bone metastases
  • No germline or somatic mutations detected

Which treatment option would you choose for this patient?